Alopi Patel

Dr. Alopi Patel


Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 April 2024 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
DLDanielle Levin
Danielle Levin
DFDaniel Van Florcke
Daniel Van Florcke
MSMonika Schmitt
Monika Schmitt
LKLucinda Kendall
Lucinda Kendall
APAlopi Patel
Alopi Patel
MKMeera Kirpekar
Meera Kirpekar
Background/Objective: Pudendal neuralgia is a distressing condition that presents with pain in the perineum. While a positive anesthetic pudendal nerve block is one of the essential criteria for diagnosing this condition, this block can also provide a therapeutic effect for those afflicted with pudendal neuralgia. There are multiple ways in which a pudendal nerve block can be performed. The objective of this study is to share our results and follow-up of fluoroscopy-guided transgluteal pudendal nerve blocks. Methods: This is a retrospective case series. Included were 101 patients who met four out of the five Nantes criteria (pain in the anatomical territory of the pudendal nerve, pain worsened by sitting, pain that does not wake the patient up at night, and no objective sensory loss on clinical examination) who did not respond to conservative treatment and subsequently underwent a fluoroscopy-guided transgluteal pudendal nerve block. Therapeutic success was defined as a 30% or greater reduction in pain. Success rates were calculated, and the duration over which that success was sustained was recorded. Results: For achieving at least 30% relief of pain, using worst-case analysis, the success rate at two weeks was 49.4% (95% CI: 38.5%, 60.3%). In addition to pain relief, patients experienced other therapeutic benefits, such as reductions in medication use and improvements in activities of daily living. Conclusions: Fluoroscopy-guided transgluteal pudendal nerve block appears to be effective in patients who have pudendal neuralgia that is resistant to conservative therapy, with good short-term success.

24 May 2024 in Current Pain and Headache Reports
Verified
Journal Article
Closed access
APAlopi Patel
Alopi Patel
VPVinit Palayeker
Vinit Palayeker
PSPaul Shekane
Paul Shekane

14 July 2023 in Regional Anesthesia & Pain Medicine
Verified
Journal Article
Closed access
PDF file
CCChristopher Cheng
Christopher Cheng
TOTony Owusu
Tony Owusu
PSPaul Shekane
Paul Shekane
APAlopi Patel
Alopi Patel
Introduction There are currently no published studies using patient reviews of pain physicians to quantitatively assess patient preferences for pain physician attributes. The aim of the present study was to use natural language processing to quantitatively analyze patient reviews of pain physicians by determining the effect of physician demographics and word frequency on positive review outcomes. Methods Using a peer-reviewed algorithm, online Healthgrades reviews of pain physicians practicing in the USA were scored according to their positive sentiment from −1 to 1. These sentiment scores and star ratings were used to compare physicians by age, gender and region of practice. Frequency analysis of words and bigrams was performed for all reviews. Results There were 15 101 reviews collected among 1275 pain physicians which showed male physicians received higher star ratings and review sentiment scores than female physicians. Pain physicians younger than 55 years received higher star ratings and sentiment scores than those of 55 years and older. Frequency analysis revealed that words most commonly used in the more positive patient reviews included ‘care’, ‘professional’, ‘patient’, ‘help’ and ‘kind’; the words most commonly used in less positive reviews included ‘pain’, ‘back’, ‘office’, ‘time’ and ‘years’. Conclusions Male and/or younger pain physicians receive more positive reviews. Patients highly rate pain physicians who are perceived as personable. Patients lowly rate physicians who are perceived as providing ineffective treatment of their pain as well as when they experience barriers to their access to care.

13 April 2026 in Pain Practice
Verified
Journal Article
Open access
JCJeroen H. A. Creemers
Jeroen H. A. Creemers
RSRachel J. H. Smits
Rachel J. H. Smits
APAlopi Patel
Alopi Patel
RDRobert T.M. Van Dongen
Robert T.M. Van Dongen
CKCornelis Kramers
Cornelis Kramers
SWSelina E. I. van der Wal
Selina E. I. van der Wal
Background: Pain is a common symptom in palliative care and affects patients' quality of life considerably. Standard analgesics are sometimes insufficient and are associated with substantial side effects. Neurolysis, the targeted destruction of nerves using thermal or chemical agents, offers an additional option for managing localized pain in palliative care. Phenol, a widely available chemical neurolytic agent known for its painless injection and hyperbaric properties when dissolved in glycerin, can effectively relieve refractory cancer pain. Methods: A literature review was conducted on the pharmacology, toxicology, and indications of phenol in interventional pain and palliative medicine. Results: Despite its use as a neurolytic agent for nearly a century, our current understanding of phenol's pharmacological properties, toxicity, and efficacy stems mainly from case series and small studies, often published decades ago. To date, no uniform guidelines exist, nor is there consensus on the optimal application of phenol in clinical practice, resulting in variability among practitioners. Chronic pain syndromes affect up to 30% of the global population, prompting the expansion of phenol neurolysis to new applications, such as joint denervation and sympathetic blocks in non‐cancer pain. Understanding the mechanism of action of phenol and standardizing its clinical use are crucial for integrating this technique into broader pain management strategies. Conclusion: This review provides a comprehensive overview of the mechanisms, indications, benefits, and safety of phenol neurolysis in pain and palliative medicine, aiming to support its evidence‐based use in clinical practice.

4 October 2024 in Pain Practice
Verified
Journal Article
Closed access
CCChristopher Cheng
Christopher Cheng
VVVikram Vasan
Vikram Vasan
APAlopi Patel
Alopi Patel
PSPaul R. Shekane
Paul R. Shekane

1 January 2025 in Case Reports in Anesthesiology
Verified
Journal Article
Open access
SSSophie E. Smith
Sophie E. Smith
APAlopi Patel
Alopi Patel
Trigger point injections (TPIs) are used to relieve myofascial pain via injection with local anesthetics. External TPIs are commonly used to treat surface muscle groups such as the trapezius, while internal transvaginal or external pelvic TPIs may be used for pelvic pain in female patients. This case series discusses two female patients with histories of myofascial pelvic pain due to high‐tone pelvic floor disorder (HTPFD) who received ultrasound‐guided external TPIs for pain relief. Patient 1 had previously received internal TPIs with no relief, while Patient 2 had previously tried botulinum toxin injections and a pudendal nerve block with some relief. In both cases, ultrasound‐guided external TPIs provided pain relief for a period of time and were repeated. This case highlights the importance of ultrasound‐guided external TPIs as part of the arsenal of treatment options for pelvic floor dysfunction treatment.